The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The prevention of type 2 diabetes
Open accessAbstract
Type 2 diabetes mellitus (T2DM) affects more than 7% of adults in the US and leads to substantial personal and economic burden. In prediabetic states insulin secretion and action--potential targets of preventive interventions--are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM in high-risk groups, although weight loss has the greatest effect. Various medications (e.g. metformin, thiazolidinediones and acarbose) can also prevent or delay T2DM. Whether diabetes-prevention strategies also ultimately prevent the development of diabetic vascular complications is unknown, but cardiovascular risk factors are favorably affected. Preventive strategies that can be implemented in routine clinical settings have been developed and evaluated. Widespread application has, however, been limited by local financial considerations, even though cost-effectiveness might be achieved at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings that both lifestyle and metformin interventions delayed or prevented diabetes in the DPPOS are consistent with results of other reports of similar interventions with lifestyle or with other antidiabetic drugs.24,25”
From 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) · cites this paper as [24]
In the citing paper
“In the Diabetes Prevention Program (DPP), metformin reduced the development of diabetes by 31% over an average of 2.8 years of follow-up (4,5).”
From Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study (2012) · cites this paper as [5]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [21]
In the citing paper
“additional benefits of the lifestyle intervention that might impact older adults: reduction in urinary incontinence20, improvement in several quality of life domains21, and improvements in cardiovascular risk factors22”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [22]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Self-citation
Research works printed but not linked: 5
- Holman RR et al. (2007) Results from the early diabetes intervention trials [abstract]. Diabetes 52 (Suppl 1): A16
- Ackermann RT et al. (2007) Translating the Diabetes Prevention Program into the community: the YMCA model [abstract]. Diabetes 67 (Suppl 1): A42
- Ratner R (2004) Community-based identification of pre-diabetes: efficient screening techniques for implementation of diabetes prevention strategies [abstract]. Diabetes 61 (Suppl 1): A290
- Seidel MC et al. (2007) Translating the Diabetes Prevention Program (DPP) in an urban underserved community: long term sustainability of positive clinical outcomes [abstract]. Diabetes 67 (Suppl 1): A42
- Simmons D et al. (1998) A pilot urban church-based programme to reduce risk factors for diabetes among Western Samoans in New Zealand. Diabet Med 15: 136–142 · doi:10.1002/(sici)1096-9136(199802)15:2<136::aid-dia530>3.0.co;2-p
Cited by
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Lack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
What Influences Saturation? Estimating Sample Sizes in Focus Group Research
Hennink, M. M., Kaiser, B. N., & Weber, M. B. (2019) · Qualitative Health Research · doi:10.1177/1049732318821692 · Cited by 1,162
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1299 · Cited by 494
Saliva: an emerging biofluid for early detection of diseases.
Lee, Y. H., & Wong, D. T. (2009) · PubMed · Cited by 488
Saliva as a diagnostic tool for oral and systemic diseases
Javaid, M. A., Ahmed, A. S., Durand, R., & Tran, S. D. (2016) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2015.08.006 · Cited by 431
A1C level and future risk of diabetes: a systematic review
Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L. (2010) · Diabetes Care · doi:10.2337/dc09-1939 · Cited by 422
Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis
Das, S. L. M., Singh, P. P., Phillips, A. R. J., Murphy, R., Windsor, J. A., & Petrov, M. S. (2014) · Gut · doi:10.1136/gutjnl-2013-305062 · Cited by 401
Ely, E. K., Gruss, S. M., Luman, E. T., Gregg, E. W., Ali, M. K., Nhim, K., Rolka, D. B., & Albright, A. L. (2017) · Diabetes Care · doi:10.2337/dc16-2099 · Cited by 386
Preventing Type 2 Diabetes in Communities Across the U.S.
Albright, A. L., & Gregg, E. W. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.009 · Cited by 297
Chronic kidney disease in low-income to middle-income countries: the case for increased screening
George, C., Mogueo, A., Okpechi, I., Echouffo-Tcheugui, J. B., & Kengne, A. P. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2016-000256 · Cited by 223
Should all women with PCOS be treated for insulin resistance?
Marshall, J. C., & Dunaif, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Kahn, H. S., Cheng, Y. J., Thompson, T. J., Imperatore, G., & Gregg, E. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00002 · Cited by 205
Diabetic Gastroparesis: Principles and Current Trends in Management
Krishnasamy, S., & Abell, T. L. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0454-9 · Cited by 199
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Self-citationComparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
Greenway, F. L., Dunayevich, E., Tollefson, G., Erickson, J., Guttadauria, M., Fujioka, K., Cowley, M. A., & for the NB-201 Study Group (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1350 · Cited by 179
Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach
Prieto-Hontoria, P. L., Pérez-Matute, P., Fernández-Galilea, M., Bustos, M., Martínez, J. A., & Moreno-Aliaga, M. J. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.11.004 · Cited by 165
Warburton, D. E. R., Gledhill, N., Jamnik, V. K., Bredin, S. S. D., McKenzie, D. C., Stone, J., Charlesworth, S., & Shephard, R. J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-062 · Cited by 156
How the association between obesity and inflammation may lead to insulin resistance and cancer
Amin, M. N., Hussain, M. S., Sarwar, M. S., Moghal, M. M. R., Das, A., Hossain, M. Z., Chowdhury, J. A., Millat, M. S., & Islam, M. S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.041 · Cited by 165
Holt, R. I. G., de Groot, M., Lucki, I., Hunter, C. M., Sartorius, N., & Golden, S. H. (2014) · Diabetes Care · doi:10.2337/dc13-2134 · Cited by 150
Bergman, M. (2012) · Endocrine · doi:10.1007/s12020-012-9830-9 · Cited by 165
Vascular disease and dementias: Paradigm shifts to drive research in new directions
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. ‐., & Arnold, S. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.007 · Cited by 150
Exercise-induced adaptations to white and brown adipose tissue
Lehnig, A. C., & Stanford, K. I. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.161570 · Cited by 131
Diet and exercise in the prevention of diabetes
Walker, K., O’Dea, K., Gomez, M., Girgis, S. T., & Colagiuri, R. (2010) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2010.01061.x · Cited by 146
Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents
Lee, Y., Lingvay, I., Szczepaniak, L. S., Ravazzola, M., Orci, L., & Unger, R. H. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.245 · Cited by 134
Medical Therapy for the Patient With Obesity
Bray, G. A., & Ryan, D. H. (2012) · Circulation · doi:10.1161/circulationaha.111.026567 · Cited by 138
Self-citationApolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment
Schipper, H. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.021 · Cited by 121
Cold and Exercise: Therapeutic Tools to Activate Brown Adipose Tissue and Combat Obesity
da Silva, C. P. V., Hernández‐Saavedra, D., White, J. D., & Stanford, K. (2019) · Biology · doi:10.3390/biology8010009 · Cited by 110
Diabetes and oral disease: implications for health professionals
Albert, D. A., Ward, A., Allweiss, P., Graves, D. T., Knowler, W. C., Kunzel, C., Leibel, R. L., Novak, K. F., Oates, T. W., Papapanou, P. N., et al. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06460.x · Cited by 120
Self-citationMetformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
Han, B., Cui, H., Kang, L., Zhang, X., Jin, Z., Lu, L., & Fan, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-3315-4 · Cited by 105
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Self-citationEffects of exercise on brown and beige adipocytes
Dewal, R. S., & Stanford, K. I. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.013 · Cited by 92
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
and the DPP Research Group, Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4928-8 · Cited by 91
Self-citationHsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91
Screening for Type 2 Diabetes and Dysglycemia
Echouffo-Tcheugui, J. B., Ali, M. K., Griffin, S. J., & Narayan, K. M. V. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq020 · Cited by 93
Zhuo, X., Zhang, P., Gregg, E. W., Barker, L., Hoerger, T. J., Pearson-Clarke, T., & Albright, A. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1115 · Cited by 82
Daivadanam, M., Absetz, P., Sathish, T., Thankappan, K. R., Fisher, E. B., Philip, N. E., Mathews, E., & Oldenburg, B. F. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-95 · Cited by 89
Differential pharmacology and benefit/risk of azilsartan compared to other sartans
Kurtz, T. W., Kajiya, & Kurtz (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s22595 · Cited by 90
Dall, T. M., Narayan, K. M. V., Gillespie, K. B., Gallo, P. D., Blanchard, T. D., Solcan, M., O’Grady, M., & Quick, W. W. (2014) · Population Health Metrics · doi:10.1186/1478-7954-12-12 · Cited by 67
Cardiovascular risk and atherosclerosis prevention
Frohlich, J. J., & Al-Sarraf, A. J. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.03.001 · Cited by 73
Busaidi, N. A., Shanmugam, P., & Manoharan, D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1125-6 · Cited by 72
Sathish, T., Williams, E. D., Pasricha, N., Absetz, P., Lorgelly, P. K., Wolfe, R. S., Mathews, E., Aziz, Z., Thankappan, K. R., Zimmet, P., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1035 · Cited by 76
Bumke‐Vogt, C., Osterhoff, M. A., Borchert, A., Guzmán, V., Sarem, Z., Birkenfeld, A. L., Bähr, V., & Pfeiffer, A. F. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104321 · Cited by 73
Nhim, K., Gruss, S. M., Porterfield, D. S., Jacobs, S., Elkins, W., Luman, E. T., Van Aacken, S., Schumacher, P., & Albright, A. (2019) · Implementation Science · doi:10.1186/s13012-019-0928-9 · Cited by 71
Nilsen, V., Bakke, P. S., & Gallefoss, F. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-893 · Cited by 91
Gao, X., Wang, Y., & Sun, G. (2016) · Nutrition · doi:10.1016/j.nut.2016.08.005 · Cited by 75
Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program
Goldberg, R. B., & Mather, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241893 · Cited by 67
Pozzo, M. J., Mociulsky, J., Martinez, E. T., Senatore, G., Farias, J. M., Sapetti, A., Sanzana, M. G., Gonzalez, P., Cafferata, A., Peloche, A., et al. (2014) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000433949.24277.19 · Cited by 69
Prediabetes: The Importance of Early Identification and Intervention
Hsueh, W. A., Orloski, L., & Wyne, K. L. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2180 · Cited by 71
Ye, Z., Chen, L., Yang, Z. H., Li, Q., Huang, Y., He, M., Zhang, S., Zhang, Z., Wang, X., Zhao, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021551 · Cited by 69
Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
Narayan, K. M. V., & Weber, M. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmc082624 · Cited by 61
Benefits of moderate weight loss in patients with type 2 diabetes
Fujioka, K. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01155.x · Cited by 61
Acceptance-based behavioral treatment for weight control: a review and future directions
Forman, E. M., Butryn, M. L., Manasse, S. M., & Bradley, L. E. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.020 · Cited by 47
Aerobic Training Effects on Glucose Tolerance in Prediabetic and Normoglycemic Humans
Jenkins, N. T., & Hagberg, J. M. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318223b5f9 · Cited by 64
Schipf, S., Haring, R., Friedrich, N., Nauck, M. A., Lau, K., Alte, D., Stang, A., Völzke, H., & Wallaschofski, H. (2010) · The Aging Male · doi:10.3109/13685538.2010.524955 · Cited by 55
Yarasheski, K. E., Cade, W. T., Overton, E. T., Mondy, K. E., Hubert, S., Laciny, E., Bopp, C., Lassa‐Claxton, S., & Reeds, D. N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00468.2010 · Cited by 51
Incretin‐Based Therapies for Type 2 Diabetes Mellitus: Current Status and Future Prospects
Drab, S. R. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.6.609 · Cited by 58
Cardiovascular Disease Risk Factors Among Women Veterans at VA Medical Facilities
Vimalananda, V. G., Miller, D. R., Christiansen, C. L., Wang, W., Tremblay, P. G., & Fincke, B. G. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2381-9 · Cited by 50
Gestational diabetes mellitus: Taking it to heart
Marcinkevage, J. A., & Narayan, K. M. V. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.10.002 · Cited by 55
Moritoh, Y., Takeuchi, K., & Hazama, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01156.x · Cited by 52
Muñoz, M. C., Giani, J. F., Dominici, F. P., Turyn, D., & Toblli, J. E. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283310e1b · Cited by 49
Jung, C. H., Jang, S. J., Ahn, J., Gwon, S. Y., Jeon, T., Kim, T. W., & Ha, T. Y. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2286 · Cited by 47
Song, Y., Chen, Y., Li, Y., Xiaoyan, L., Cui, J., Cheng, Y., Zhao, L., & Zhao, G. (2017) · Oncotarget · doi:10.18632/oncotarget.23317 · Cited by 46
Gregg, E. W., Boyle, J. P., Thompson, T. J., Barker, L. E., Albright, A. L., & Williamson, D. F. (2013) · Population Health Metrics · doi:10.1186/1478-7954-11-18 · Cited by 47
Do we need anti‐obesity drugs?
Hainer, V., & Hainerová, I. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2349 · Cited by 51
Chen, F., Zhang, N., Ma, X., Huang, T., Shao, Y., Wu, C., & Wang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143868 · Cited by 44
RetractedHoskin, M. A., Bray, G. A., Hattaway, K., Khare-Ranade, P., Pomeroy, J. J., Semler, L., Weinzierl, V., & Wylie‐Rosett, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0094-2 · Cited by 44
Self-citationHao, B., Xiao, Y., Song, F., Long, X., Huang, J., Tian, M., Deng, S., & Wu, Q. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3346 · Cited by 43
RetractedExercise training modalities in prediabetes: a systematic review and network meta-analysis
Zhang, H., Guo, Y., Hua, G., Guo, C., Gong, S.-M., Li, M., & Yang, Y. M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1308959 · Cited by 48
Echouffo-Tcheugui, J. B., Dieffenbach, S. D., & Kengne, A. P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.023 · Cited by 38
Rapid Deterioration of Insulin Secretion in Obese Adolescents Preceding the Onset of Type 2 Diabetes
Elder, D. A., Hornung, L. N., Herbers, P. M., Prigeon, R. L., Woo, J. G., & D’Alessio, D. A. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.11.029 · Cited by 44
Gele, A. A., Torheim, L. E., Pettersen, K. S., & Kumar, B. (2015) · Journal of Diabetes Research · doi:10.1155/2015/549795 · Cited by 49
Batitucci, G., Brandão, C., de Carvalho, F. G., Marchini, J. S., Pfrimer, K., Ferriolli, E., Cunha, F. Q., Papoti, M., Terrazas, S. I. B. M., Junqueira‐Franco, M. V. M., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154741 · Cited by 36
Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)
Souto, S. B., Souto, E. B., Braga, D. C., & Medina, J. L. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1038-z · Cited by 37
Screening for hyperglycemia in the developing world: Rationale, challenges and opportunities
Echouffo-Tcheugui, J. B., Mayige, M. T., Ogbera, A. O., Sobngwi, E., & Kengne, A. P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.003 · Cited by 38
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Narayan, K. M. V., & Williamson, D. F. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1148-9 · Cited by 38
Narayan, K. M. V., Echouffo-Tcheugui, J. B., Mohan, V., & Ali, M. K. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1040 · Cited by 35
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
Park, J., Kim, W. G., Zhao, L., Enomoto, K., Willingham, M. C., & Cheng, S.-Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8989 · Cited by 34
Gregg, E. W., Patorno, E., Karter, A. J., Mehta, R., Huang, E. S., White, M., Patel, C. J., McElvaine, A. T., Cefalu, W. T., Selby, J. V., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1438 · Cited by 40
Role of Yoga in Preventing and Controlling Type 2 Diabetes Mellitus
Sharma, M., & Knowlden, A. P. (2012) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587212438899 · Cited by 37
Metformin Inhibits Esophagus Cancer Proliferation through Upregulation of USP7
Xu, Y., & Lu, S. Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354517 · Cited by 36
Waxler, J. L., OʼBrien, K., Delahanty, L. M., Meigs, J. B., Florez, J. C., Park, E. R., Pober, B. R., & Grant, R. W. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9486-x · Cited by 37
Self-citationMetformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo
Shen, C., Wei, W., Qiu, Z., Song, H.-J., Zhang, X., Sun, Z., & Luo, Q. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0134 · Cited by 33
Navigating the Choices for Diabetes Prevention
Nathan, D. M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1002322 · Cited by 35
Self-citationMetformin and JQ1 synergistically inhibit obesity-activated thyroid cancer
Park, S., Willingham, M. C., Qi, J., & Cheng, S.-Y. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0071 · Cited by 32
Saaristo, T., Moilanen, L., Jokelainen, J. J., Korpi-Hyövälti, E., Vanhala, M. J., Saltevo, J. T., NISKANEN, L. K., Peltonen, M., Oksa, H. H., Cederberg, H., et al. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.05.005 · Cited by 34
Liu, A., Silvestre, M. P., & Poppitt, S. D. (2015) · Advances in Nutrition · doi:10.3945/an.115.008821 · Cited by 33
Dallam, G. M., & Foust, C. P. (2012) · Health Promotion Practice · doi:10.1177/1524839912437786 · Cited by 33
Shahid, M., Fazry, S., Azfaralariff, A., Najm, A. A., Law, D. S. N., & Mackeen, M. M. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.102285 · Cited by 27
The role of diet in the prevention and management of several equine diseases
Secombe, C. J., & Lester, G. D. (2011) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2011.12.017 · Cited by 36
Curcumin alleviates lung injury in diabetic rats by inhibiting nuclear factor‐κB pathway
Zhang, F., Yang, F., Zhao, H., & An, Y. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12438 · Cited by 40
Regulation of Insulin Action by Diet and Exercise
Schmidt, S. L., & Hickey, M. S. (2009) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2009.04.185 · Cited by 30
Prevention of type 2 diabetes: the long and winding road
Misra, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61631-7 · Cited by 27
Juul, L., Andersen, V. J., Arnoldsen, J., & Maindal, H. T. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.07.002 · Cited by 30
Masania, J., Faustmann, G., Anwar, A., Hafner-Gießauf, H., Rajpoot, N., Grabher, J., Rajpoot, K., Tiran, B., Obermayer-Pietsch, B. M., Winklhofer‐Roob, B. M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4851323 · Cited by 28
Gestational diabetes mellitus: A window of opportunity
Kalra, S., Malik, S., & John, M. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83395 · Cited by 27
Metadata
- Authors
- F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M.
- Affiliations
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- VA Puget Sound Health Care System (US)
- Indiana University (US)
- Louisiana State University (US)
- The University of Texas at San Antonio Health Science Center (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Harvard University (US)
- Corresponding author
- Crandall, Jill P
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-05-20
- Volume
- 4
- Issue
- 7
- Pages
- 382-393
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- PMC
- PMC2573045
- OpenAlex
- W2034419419
- Cited by
- 261
- References
- 100
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 16 · 2023: 24 · 2022: 9 · 2021: 20 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 9 · 2015: 18 · 2014: 15 · 2013: 12 · 2012: 28
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK069000, U01DK048489)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, prediabetes, insulin secretion, insulin resistance, lifestyle modification, weight loss, physical activity, metformin, thiazolidinediones, acarbose, cardiovascular risk factors, cost-effectiveness, high-risk groups
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Life Style, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.